Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Abbott HbA1c Test FDA Cleared to Diagnose Diabetes

Abbott HbA1c Test FDA Cleared to Diagnose Diabetes

Jun 21, 2018
|
staff reporter

NEW YORK (360Dx) – Abbott said on Thursday that the US Food and Drug Administration has cleared the company's Afinion HbA1c Dx assay to help diagnose diabetes mellitus and assess a patient's risk of developing the disease.

The rapid point-of-care assay was cleared to run on Abbott's Afinion AS100 Analyzer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

  2. FDA Grants EUAs for PCR Coronavirus Tests, Nasal Swab Self-Collection Kit

  3. Sysmex Nabs Japan Approval for Automated Hematology Analyzer to Diagnose Malaria

  4. InBios International Gets Emergency Use Authorization for Second Coronavirus Antibody Test

  5. Bladder Cancer Test From KDx Diagnostics Gets CE Mark

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.